CERVICAL CANCER BY FIGO STAGE 2018
Clinical trials for CERVICAL CANCER BY FIGO STAGE 2018 explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER BY FIGO STAGE 2018 trials appear
Sign up with your email to follow new studies for CERVICAL CANCER BY FIGO STAGE 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to stop aggressive cervical cancer from coming back
Disease control Not yet recruitingThis study is testing if adding two drugs, pembrolizumab and lenvatinib, after standard chemoradiation and brachytherapy can better control high-risk, locally advanced cervical cancer and prevent it from returning. It will involve about 87 adults with specific high-risk forms of …
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: PHASE2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New approach aims to protect patients' blood cells during aggressive cervical cancer treatment
Disease control Not yet recruitingThis study tests whether carefully avoiding bone marrow during pelvic radiation can reduce severe blood-related side effects in women receiving combined chemotherapy and radiation for advanced cervical cancer. Researchers want to see if this bone-sparing technique decreases dange…
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC